Michael Henderson

Dr. Michael Henderson, MD, is an Independent Director at Spyre Therapeutics, Inc., a Chief Executive Officer at Origin Biosciences, Inc. and a Chief Executive Officer at QED Therapeutics, Inc. He is on the Board of Directors at Spyre Therapeutics, Inc., Adrenas Therapeutics, Inc., Quartz Therapeutics, Inc. and Therasis, Inc. Dr. Henderson was previously employed as a Chief Executive Officer & Director by Apogee Therapeutics, Inc., an Independent Director by ARYA Sciences Acquisition Corp.
IV, a Chief Business Officer by BridgeBio Pharma, Inc., a Senior Associate by McKinsey & Co., Inc., and a Co-Founder by PellePharm, Inc. He also served on the board at Bridgebio Oncology Therapeutics, Inc. He received his undergraduate degree from Harvard University and a doctorate degree from Stanford University.